Org.nr 990 646 066 2018 → 2019 Year-over-year analysis

NYKODE THERAPEUTICS ASA: årsregnskap 2019 vs 2018

Fresh owner capital

approved 2020-04-22; registry 2020-06-24; journal 2020 482212

Summary

What changed

Comparing Årsregnskap 2019 with 2018 for NYKODE THERAPEUTICS ASA. Revenue 12.04m NOK → 12.45m NOK (+3.4%). Equity 140.07m NOK → 268.44m NOK.

On the constructive side: revenue rose; equity strengthened; cash rose.

Also worth watching: book investments changed. All figures are taken from the published annual accounts for NYKODE THERAPEUTICS ASA.

At a glance

Revenue

12.04m NOK 12.45m NOK

+3.4%

Operating result

n/m -13.94m NOK

—

Net result

n/m -13.70m NOK

—

Equity

140.07m NOK 268.44m NOK

+91.6%

Cash

32.44m NOK 89.26m NOK

+175.1%

Total assets

153.34m NOK 292.25m NOK

+90.6%

↑
Revenue rose

Operating income / revenue moved from 12.04m NOK to 12.45m NOK (+3.4% YoY). Calculated
↑
Equity strengthened

Book equity 140.07m NOK → 268.44m NOK (equity ratio 91.3% → 91.9%). Calculated
↑
Cash rose

Bank deposits 32.44m NOK → 89.26m NOK (+175.1% YoY). Calculated
↑
Owners injected capital

Paid-in equity rose 290.20m NOK → 514.52m NOK (+224.32m NOK). Reported fact

·
Book investments changed

Investment / intangible book value 74.6k NOK → 35.6k NOK. Reported fact